
Oncolytics Biotech Inc
ONCYTORONTO STOCK EXCHANGEKey Statistics
Open
$0.9500
Day High
$1.07
Day Low
$0.9100
Prev. Close
$0.9400
VolumeShares traded today.
2.83M
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$124.13M
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
-3.47
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$1.51
52W LowLowest price over the past 52 weeks.
$0.3300
50D MAAverage closing price over the last 50 trading days.
$0.9347
200D MAAverage closing price over the last 200 trading days.
$1.04
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
+31.6%1M
+19.4%6M
+1.0%YTD
+5.7%1Y
+205.9%About
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.
www.oncolyticsbiotech.com/Company Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade ONCY
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.